This activity is supported by educational grants from Purdue Pharma LP, Teva Pharmaceuticals, and Zogenix, Inc.

The Pharmacist’s Role in Opioid Analgesia: Supporting the Pain Patient While Preventing Overdose, Misuse, and Diversion

Faculty

Mara N. Villanueva, PharmD

Clinical Pharmacy Specialist

Pharmacy Medication Management

and Analytics

The University of Texas

MD Anderson Cancer Center

Houston, Texas

Educational Objectives

At the conclusion of this educational activity, participants should be able to:

• Examine the risk factors associated with the highest rates of opioid overdose.
• Identify the characteristics and red flags of patients who intend to use or distribute opioids for non-medical reasons.
• Review the information that is important to communicate to patients regarding appropriate opioid medication use, storage, and disposal.
• Describe how pharmacists can support the current Risk Evaluation and Mitigation Strategy programs for extended-release, long-acting, and transmucosal immediate-release fentanyl opioid products, and identify the tools available to prevent opioid misuse, diversion, and abuse.

Intended Audience

Pharmacists

Release date: July 8, 2014

Expiration date: July 8, 2016

Estimated time to complete activity: 1.5 hours

Fee: Free

Click here to view this activity.

Click here to view this activity. - See more at: http://www.pharmacytimes.com/publications/issue/2014/June2014/Optimizing-the-Management-of-Asthma-The-Critical-Role-of-the-Pharmacist#sthash.7ZeRdjp8.dpuf

Click here to view this activity.

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-14-062-H03-P. The activity is available for CE credit through July 8, 2016.